COMMUNIQUÉS West-GlobeNewswire

Arbutus to Participate at the 2018 B. Riley FBR Healthcare Conference
28/08/2018
WARMINSTER, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS), an industry-leading Hepatitis B Virus (HBV) therapeutic solutions company, today announced that Dr. Michael Sofia, Arbutus [...]
AzurRx BioPharma to Present at the Rodman & Renshaw 20th Annual Global Investment Conference on September 5th
28/08/2018
BROOKLYN, N.Y., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AzurRx BioPharma, Inc. (NASDAQ: AZRX ) (“AzurRx” or the “Company”), a company specializing in the development of non-systemic, recombinant therapies for gastrointestinal [...]
Yield10 Bioscience to Present at the 20th Annual Rodman and Renshaw Global Investment Conference in New York City September 4-6, 2018
28/08/2018
WOBURN, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (NASDAQ:YTEN), a company focused on developing new technologies to achieve step-change improvements in crop yield to enhance global food security [...]
Hemispherx Releases Recently Manufactured Ampligen for Pancreatic Cancer Early Access Program in the Netherlands to Fill Stock Order
28/08/2018
ORLANDO, Fla., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE American: HEB) announced today that the new Ampligen batch manufactured earlier this year is now released for patients' use in the [...]
Onconova Therapeutics to Present at the Rodman & Renshaw 20th Annual Global Investment Conference in New York City
28/08/2018
NEWTOWN, Pa., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3-stage biopharmaceutical company focused on discovering and developing novel products to treat cancer, with a primary [...]
ChemoCentryx to Present at Two Upcoming Investor Conferences
28/08/2018
MOUNTAIN VIEW, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at two upcoming investor [...]
Cytokinetics Awards Inaugural Communications Fellowship To The ALS Association Golden West Chapter
28/08/2018
SOUTH SAN FRANCISCO, Calif., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that The ALS Association Golden West Chapter is the inaugural recipient of the Cytokinetics [...]
Viveve to Present at 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018
ENGLEWOOD, Colo., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Viveve Medical, Inc. ("Viveve") (NASDAQ: VIVE), a medical technology company focused on women's intimate health, today announced that Scott Durbin, chief executive [...]
Avid Bioservices to Exhibit at the 2018 BioProcess International Conference & Exhibition
28/08/2018
-- Corporate Booth to Include Virtual Tour of Myford Late-Stage Clinical and Commercial Biomanufacturing Facility Highlighting Immediately Available 2,000-Liter Scale Bioreactor Capacity -- TUSTIN, Calif., Aug. 28, 2018 [...]
Sirona Biochem Receives $500,000 USD Milestone Payment from Wanbang Biopharmaceuticals
28/08/2018
VANCOUVER, British Columbia, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Sirona Biochem Corp . (TSX-V: SBM) (FSE: ZSB) (Xetra: ZSB) (the “ Company ”) announced that it has received the $500,000 USD milestone payment from partner [...]
Medical City Plano, a HCA Healthcare Facility, Adopts iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Breast Cancer
28/08/2018
Leading center becomes first in Texas to offer intraoperative radiation therapy with the advanced Xoft System to enhance patient care NASHUA, N.H. and PLANO, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) -- iCAD, Inc . (NASDAQ [...]
Nemaura Medical Strengthens Manufacturing Team in Preparation for SugarBEAT® Commercial Launch.
28/08/2018
LOUGHBOROUGH, England. Nemaura Medical Inc. (NASDAQ: NMRD), a medical technology company developing sugarBEAT® as a non-invasive glucose trending device for use by persons with diabetes and pre-diabetics today announced [...]
AVROBIO, Inc. to Present at Upcoming Investor Conferences
28/08/2018
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- AVROBIO, Inc . (NASDAQ:AVRO) (the “Company”), a Phase 2 clinical stage gene therapy company focused on developing potentially curative lentiviral-based gene therapies [...]
OPKO Health’s BioReference Laboratories to Participate in the National Cancer Institute NCI-MATCH (Molecular Analysis for Therapy Choice) Phase II Clinical Trial
28/08/2018
MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that BioReference Laboratories, Inc. (BRL), an OPKO Health company and the third largest clinical laboratory in the United States [...]
Progressive Care Inc. Earns International Media Coverage in Top Industry Outlets on Its Healthcare Technology Expertise
28/08/2018
MIAMI, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that Chief Executive Officer S. Parikh Mars has earned [...]
Immunomedics Announces Participation in Upcoming Healthcare Conferences
28/08/2018
MORRIS PLAINS, N.J., Aug. 28, 2018 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]
VBI Vaccines to Present at the 20th Annual Rodman & Renshaw Global Investment Conference
28/08/2018
CAMBRIDGE, Mass., Aug. 28, 2018 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (NASDAQ:VBIV) (“VBI”), a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today [...]
Aeglea BioTherapeutics to Present at 2018 Wells Fargo Healthcare Conference
28/08/2018
Company to Webcast Presentation on Wednesday, September 5 at 10:50 am ET AUSTIN, Texas, Aug. 28, 2018 (GLOBE NEWSWIRE) -- Aeglea BioTherapeutics, Inc. (NASDAQ:AGLE), a clinical-stage biotechnology company that designs [...]
Spero Therapeutics to Present New Data for SPR994 and SPR206 at ESCMID/ASM 2018 Conference
28/08/2018
Highlights include eleven presentations covering SPR994’s pharmacokinetics and pharmacodynamics, SPR206’s broad spectrum of activity and favorable toxicology, and urinary tract infection epidemiology CAMBRIDGE, Mass., [...]

Pages